肿瘤,乳腺的临床试验
总计108762个结果
-
The University of Hong KongEndomagnetics Ltd.招聘中
-
Instituto Brasileiro de Controle do Cancer招聘中
-
Erasme University HospitalUniversity Hospital, Lille招聘中
-
Borstkanker Onderzoek GroepUMC Utrecht; Erasmus Medical Center; Servier; BOOG Study Center主动,不招人
-
HiberCell, Inc.Merck Sharp & Dohme LLC完全的
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLC; Celgene Corporation完全的
-
AryoGen Pharmed Co.完全的
-
Rna Diagnostics Inc.招聘中
-
Karolinska University HospitalKarolinska Institutet; Lunit Inc.; Capio Sankt Görans Hospital主动,不招人
-
University of TennesseeUniversity of Tennessee West Cancer Center完全的
-
Centre Hospitalier Emile RouxUniversity Hospital, Clermont-Ferrand; Walisco招聘中
-
The First Hospital of Jilin UniversityFirst Affiliated Hospital Xi'an Jiaotong University; Qingdao University; First Hospital of China... 和其他合作者招聘中
-
Emory UniversityNational Cancer Institute (NCI); West Cancer Center; Vector Oncology完全的
-
Institute of Cancer Research, United KingdomCancer Research UK; University of Manchester; University of Sussex完全的
-
International Cancer Research Group, United Arab...Pfizer; AstraZeneca; Genomic Health®, Inc.完全的女性乳腺肿瘤阿拉伯联合酋长国, 阿尔及利亚, 埃及, 约旦, 黎巴嫩, 摩洛哥, 沙特阿拉伯, 突尼斯
-
University College, LondonRoyal Free Hospital NHS Foundation Trust完全的
-
Universitaire Ziekenhuizen KU Leuven完全的
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University Cancer Hospital... 和其他合作者招聘中
-
MBQ PharmaCongressionally Directed Medical Research Programs招聘中
-
National Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | 男性乳腺癌 | 炎性乳腺癌 | 成人实体瘤美国
-
Mackay Medical CollegeTaipei Veterans General Hospital, Taiwan完全的
-
Alison StopeckEli Lilly and Company; AstraZeneca撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Texas Appropriation for Rare and Aggressive diseases招聘中